1. Home
  2. IFF vs DXCM Comparison

IFF vs DXCM Comparison

Compare IFF & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Flavors & Fragrances Inc.

IFF

International Flavors & Fragrances Inc.

HOLD

Current Price

$78.24

Market Cap

19.8B

Sector

Industrials

ML Signal

HOLD

Logo DexCom Inc.

DXCM

DexCom Inc.

HOLD

Current Price

$75.43

Market Cap

28.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFF
DXCM
Founded
1833
1999
Country
United States
United States
Employees
21500
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.8B
28.1B
IPO Year
2010
2005

Fundamental Metrics

Financial Performance
Metric
IFF
DXCM
Price
$78.24
$75.43
Analyst Decision
Buy
Strong Buy
Analyst Count
12
21
Target Price
$89.09
$85.33
AVG Volume (30 Days)
1.9M
6.3M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
2.32%
N/A
EPS Growth
N/A
47.18
EPS
0.66
0.51
Revenue
N/A
N/A
Revenue This Year
N/A
$14.46
Revenue Next Year
$3.11
$12.31
P/E Ratio
$117.77
$147.96
Revenue Growth
N/A
N/A
52 Week Low
$59.14
$54.11
52 Week High
$84.45
$89.07

Technical Indicators

Market Signals
Indicator
IFF
DXCM
Relative Strength Index (RSI) 58.62 62.32
Support Level $68.50 $62.86
Resistance Level $84.17 $81.64
Average True Range (ATR) 2.35 2.87
MACD 0.23 0.09
Stochastic Oscillator 66.55 59.61

Price Performance

Historical Comparison
IFF
DXCM

About IFF International Flavors & Fragrances Inc.

International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations and partners with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrance producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients, though IFF plans to divest it in a deal expected to close in 2027.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Share on Social Networks: